title: Isolating the role of elevated Phlda2 in asymmetric late fetal growth restriction in mice.
abstract: Pleckstrin homology-like domain family A member 2 (PHLDA2) is a maternally expressed imprinted gene whose elevated expression has been linked to fetal growth restriction in a number of human studies. In mice, Phlda2 negatively regulates placental growth and limits the accumulation of placental glycogen. We previously reported that a three-copy transgene spanning the Phlda2 locus drove a fetal growth restriction phenotype late in gestation, suggesting a causative role for PHLDA2 in human growth restriction. However, in this mouse model, Phlda2 was overexpressed by fourfold, alongside overexpression of a second imprinted gene, Slc22a18. Here, we genetically isolate the role of Phlda2 in driving late fetal growth restriction in mice. We furthermore show that this Phlda2-driven growth restriction is asymmetrical, with a relative sparing of the brain, followed by rapid catch-up growth after birth, classic features of placental insufficiency. Strikingly, fetal growth restriction showed strain-specific differences, being apparent on the 129S2/SvHsd (129) genetic background and absent on the C57BL6 (BL6) background. A key difference between these two strains is the placenta. Specifically, BL6 placentae possess a more extensive endocrine compartment and substantially greater stores of placental glycogen. Taken together, these data support a direct role for elevated Phlda2 in limiting fetal growth but also suggest that growth restriction only manifests when there is limited placental reserve. These findings should be taken into account in interpreting the results from human studies.
authors.affiliation: Cardiff School of Biosciences, Cardiff University, Cardiff CF10 3AX, UK.
authors.forename: Simon J
authors.initials: SJ
authors.lastname: Tunster
authors.affiliation: Cardiff School of Biosciences, Cardiff University, Cardiff CF10 3AX, UK.
authors.forename: Mathew
authors.initials: M
authors.lastname: Van De Pette
authors.affiliation: Cardiff School of Biosciences, Cardiff University, Cardiff CF10 3AX, UK. JohnRM@cf.ac.uk.
authors.forename: Rosalind M
authors.initials: RM
authors.lastname: John
mesh_terms: D000818:Animals; D005317:Fetal Growth Retardation; D051379:Mice; D009687:Nuclear Proteins / Q000235:genetics*
chemical_list: D009687:Nuclear Proteins; C109277:TSSC3 protein
keywords: Asymmetric; Fetal growth restriction; Phlda2
references.citation: Placenta. 2012 Jun;33(6):480-6
references.pmid: 22465419
references.citation: J Clin Hypertens (Greenwich). 2001 Jan-Feb;3(1):29-31
references.pmid: 11416679
references.citation: J Physiol. 2009 Jul 15;587(Pt 14):3459-72
references.pmid: 19451204
references.citation: Bone. 2012 Jan;50(1):337-42
references.pmid: 22100507
references.citation: Eur J Obstet Gynecol Reprod Biol. 2004 Sep 10;116(1):3-15
references.pmid: 15294360
references.citation: Hum Mol Genet. 1997 Nov;6(12):2021-9
references.pmid: 9328465
references.citation: Nat Protoc. 2008;3(6):1101-8
references.pmid: 18546601
references.citation: Curr Opin Cell Biol. 1996 Jun;8(3):348-53
references.pmid: 8743885
references.citation: Placenta. 2010 Mar;31(3):186-91
references.pmid: 20092892
references.citation: Physiol Rev. 2012 Oct;92(4):1543-76
references.pmid: 23073626
references.citation: Epigenetics. 2009 May 16;4(4):235-40
references.pmid: 19483473
references.citation: Proc Natl Acad Sci U S A. 2002 May 28;99(11):7490-5
references.pmid: 12032310
references.citation: Hum Mol Genet. 2001 Jul 15;10(15):1601-9
references.pmid: 11468278
references.citation: Dev Biol. 2011 Mar 15;351(2):277-86
references.pmid: 21238448
references.citation: J Med Genet. 2012 Nov;49(11):689-97
references.pmid: 23042810
references.citation: Placenta. 2012 Feb;33(2):94-9
references.pmid: 22154689
references.citation: Dev Dyn. 2006 Dec;235(12):3280-94
references.pmid: 17039549
references.citation: Genesis. 2005 Jun;42(2):91-103
references.pmid: 15887267
references.citation: Arch Intern Med. 2000 May 22;160(10):1472-6
references.pmid: 10826460
references.citation: Mol Cell Biol. 2010 Jan;30(1):295-306
references.pmid: 19884348
references.citation: Dev Biol. 2006 Jun 1;294(1):67-82
references.pmid: 16579983
references.citation: Placenta. 2014 Aug;35(8):528-32
references.pmid: 24953163
references.citation: Reproduction. 2013 Apr 29;145(5):R117-37
references.pmid: 23445556
references.citation: Am J Hum Genet. 2012 Apr 6;90(4):715-9
references.pmid: 22444668
references.citation: BMJ. 1991 Sep 21;303(6804):671-5
references.pmid: 1912913
references.citation: J Appl Physiol. 1970 Feb;28(2):234-6
references.pmid: 5413312
references.citation: Dev Biol. 2008 Aug 1;320(1):79-91
references.pmid: 18550048
references.citation: Placenta. 2006 Jun-Jul;27(6-7):540-9
references.pmid: 16125225
references.citation: Dev Biol. 2007 Dec 1;312(1):258-71
references.pmid: 17961533
references.citation: Matern Child Health J. 2012 Oct;16(7):1525-41
references.pmid: 22124801
references.citation: Int J Dev Neurosci. 2013 Oct;31(6):406-14
references.pmid: 23201144
references.citation: BMJ. 1990 Nov 17;301(6761):1111
references.pmid: 2252919
references.citation: Philos Trans R Soc Lond B Biol Sci. 2004 Sep 29;359(1449):1359-66
references.pmid: 15347527
references.citation: Nat Clin Pract Nephrol. 2006 Dec;2(12):700-7
references.pmid: 17124527
references.citation: J R Coll Physicians Lond. 1994 Nov-Dec;28(6):544-51
references.pmid: 7884713
references.citation: J Mol Med (Berl). 2007 Apr;85(4):379-87
references.pmid: 17180344
references.citation: Genes Dev. 1988 Dec;2(12A):1639-46
references.pmid: 3215514
references.citation: Alcohol Clin Exp Res. 2011 Mar;35(3):559-65
references.pmid: 21143252
references.citation: Endocr Rev. 2007 Apr;28(2):219-51
references.pmid: 17322454
references.citation: Placenta. 2012 Feb;33(2):124-7
references.pmid: 22153913
references.citation: Mech Dev. 2004 Oct;121(10):1199-210
references.pmid: 15327781
references.citation: Hum Mol Genet. 2012 Jan 1;21(1):10-25
references.pmid: 21920939